These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
571 related items for PubMed ID: 28640257
1. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L. Cell Death Dis; 2017 Jun 22; 8(6):e2892. PubMed ID: 28640257 [Abstract] [Full Text] [Related]
2. MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-κB signaling pathway. Hu J, Wang Z, Pan Y, Ma J, Miao X, Qi X, Zhou H, Jia L. Int J Biochem Cell Biol; 2018 Jan 22; 94():79-88. PubMed ID: 29208566 [Abstract] [Full Text] [Related]
3. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway. Xu J, Xiao Y, Liu B, Pan S, Liu Q, Shan Y, Li S, Qi Y, Huang Y, Jia L. J Exp Clin Cancer Res; 2020 Mar 24; 39(1):54. PubMed ID: 32209115 [Abstract] [Full Text] [Related]
4. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4. Ma X, Dong W, Su Z, Zhao L, Miao Y, Li N, Zhou H, Jia L. Cell Death Dis; 2016 Dec 29; 7(12):e2561. PubMed ID: 28032858 [Abstract] [Full Text] [Related]
5. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer. Miyamoto K, Seki N, Matsushita R, Yonemori M, Yoshino H, Nakagawa M, Enokida H. Br J Cancer; 2016 Jul 26; 115(3):354-63. PubMed ID: 27310702 [Abstract] [Full Text] [Related]
6. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma. Kurozumi A, Kato M, Goto Y, Matsushita R, Nishikawa R, Okato A, Fukumoto I, Ichikawa T, Seki N. Int J Oncol; 2016 May 26; 48(5):1837-46. PubMed ID: 26983694 [Abstract] [Full Text] [Related]
7. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4. Zhao L, Feng X, Song X, Zhou H, Zhao Y, Cheng L, Jia L. Oncol Rep; 2016 Aug 26; 36(2):1007-15. PubMed ID: 27375041 [Abstract] [Full Text] [Related]
8. Overexpression of miRNA 26a and 26b with MMP-9 are valuable diagnostic biomarkers for colorectal cancer patients. Farouk S, El-Shenawy R, Khairy AM, Bader El-Din NG. Biomark Med; 2023 Feb 26; 17(3):159-169. PubMed ID: 37097025 [Abstract] [Full Text] [Related]
9. MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation. Zheng Q, Zhang D, Yang YU, Cui X, Sun J, Liang C, Qin H, Yang X, Liu S, Yan Q. Cell Death Differ; 2017 Dec 26; 24(12):2161-2172. PubMed ID: 28914881 [Abstract] [Full Text] [Related]
10. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4. Zhang Y, Zhang D, Lv J, Wang S, Zhang Q. Biomed Pharmacother; 2018 Dec 26; 108():1039-1047. PubMed ID: 30372804 [Abstract] [Full Text] [Related]
11. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer. Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa T, Seki N. Int J Oncol; 2015 Aug 26; 47(2):710-8. PubMed ID: 26063484 [Abstract] [Full Text] [Related]
12. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells. Ren T, Hou J, Liu C, Shan F, Xiong X, Qin A, Chen J, Ren W. Biomed Pharmacother; 2019 Sep 26; 117():109171. PubMed ID: 31261026 [Abstract] [Full Text] [Related]
13. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z. J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530 [Abstract] [Full Text] [Related]
14. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH. Hepatology; 2014 Aug 19; 60(2):598-609. PubMed ID: 24616020 [Abstract] [Full Text] [Related]
15. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways. Fukumoto I, Hanazawa T, Kinoshita T, Kikkawa N, Koshizuka K, Goto Y, Nishikawa R, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Br J Cancer; 2015 Mar 03; 112(5):891-900. PubMed ID: 25668004 [Abstract] [Full Text] [Related]
16. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. Ma YL, Zhang P, Wang F, Moyer MP, Yang JJ, Liu ZH, Peng JY, Chen HQ, Zhou YK, Liu WJ, Qin HL. J Cell Mol Med; 2011 Sep 03; 15(9):1941-54. PubMed ID: 20831567 [Abstract] [Full Text] [Related]
17. Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. Liu M, Zhi Q, Wang W, Zhang Q, Fang T, Ma Q. Biomed Pharmacother; 2015 Feb 03; 69():214-20. PubMed ID: 25661360 [Abstract] [Full Text] [Related]
18. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Li W, Chang J, Wang S, Liu X, Peng J, Huang D, Sun M, Chen Z, Zhang W, Guo W, Li J. Oncotarget; 2015 Sep 15; 6(27):24448-62. PubMed ID: 26259252 [Abstract] [Full Text] [Related]
19. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p. Gharib E, Rejali L, Piroozkhah M, Zonoobi E, Nasrabadi PN, Arabsorkhi Z, Baghdar K, Shams E, Sadeghi A, Kuppen PJK, Salehi Z, Nazemalhosseini-Mojarad E. J Transl Med; 2024 May 08; 22(1):439. PubMed ID: 38720389 [Abstract] [Full Text] [Related]
20. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer. Vishnubalaji R, Hamam R, Abdulla MH, Mohammed MA, Kassem M, Al-Obeed O, Aldahmash A, Alajez NM. Cell Death Dis; 2015 Jan 22; 6(1):e1614. PubMed ID: 25611389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]